Concepedia

Jens E. Ruhe

JE

Statistics

Publications

6

Citations

478

H-Index

6

Active since

2006

Affiliations

Max Planck Institute of Biochemistry(Current)

Institute of Medical Biology

Technical University of Munich

Max Planck Society

University of Chieti-Pescara

Jens E. Ruhe is an author at Max Planck Institute of Biochemistry specializing in molecular oncology, oncology, and medicine.

Publications per year

2006–2015

6

Publications

6

Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention

Han Kiat Ho, Sharon Pok, Sylvia Streit et al. · Journal of Hepatology · 2008 · 194 citations

, , +11

Genetic Alterations in the Tyrosine Kinase Transcriptome of Human Cancer Cell Lines

Jens E. Ruhe, Sylvia Streit, Stefan Hart et al. · Cancer Research · 2007 · 86 citations

, , +12

The FGFR4 Y367C mutant is a dominant oncogene in MDA-MB453 breast cancer cells

Andreas Roidl, Priscilla Foo, Willy Wong et al. · Oncogene · 2009 · 67 citations

, , +12

Clinical Translation and Validation of a Predictive Biomarker for Patritumab, an Anti-human Epidermal Growth Factor Receptor 3 (HER3) Monoclonal Antibody, in Patients With Advanced Non-small Cell Lung Cancer

Jeanne Mendell, Daniel J. Freeman, Wenqin Feng et al. · EBioMedicine · 2015 · 49 citations · Full text

, , +17

EGFR signaling leads to downregulation of PTP-LAR via TACE-mediated proteolytic processing

Jens E. Ruhe, S. Streit, Sarah Hart et al. · Cellular Signalling · 2006 · 43 citations

, , +11

1–5 of 6